BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 4216252)

  • 1. Self-experiments with ingestion of various bacteria.
    Rédey B
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):45-62. PubMed ID: 4216252
    [No Abstract]   [Full Text] [Related]  

  • 2. Live oral Shigella vaccine: vaccination schedule and the effect of booster dose.
    Mel DM; Arsic BL; Radovanovic ML; Litvinjenko SA
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):109-14. PubMed ID: 4613128
    [No Abstract]   [Full Text] [Related]  

  • 3. Technological aspect of the production of live dysentery vaccines for oral administration.
    Denchev V; Nenkov P; Vitanov T; Sumerska T; Marinova S; Vassilev T; Panova I; Bratoeva M; Linde K
    Acta Microbiol Hung; 1991; 38(2):121-6. PubMed ID: 1805499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Safety, reactivity and effectiveness testing of live shigella flexneri vaccines in laboratory animals and children (author's transl)].
    Sergeev VV; Elkina SI; Solodnikov YP; Shuster BY; Sergeeva GS; Bulk VF; Bobkin SV
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):121-8. PubMed ID: 4216247
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
    Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127
    [No Abstract]   [Full Text] [Related]  

  • 6. [Live shigella flexneri 2a and shigella sonnei vaccines (author's transl)].
    Belaia IuA; Gekker VD; Kuz'min SN; Sergeeva NS
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):63-9. PubMed ID: 4216253
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigenicity testing of inactivated oral enteric bacterial vaccines for human use.
    Joó I
    Dev Biol Stand; 1976; 33():75-9. PubMed ID: 782974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of antisera to detect virulent Yersinia enterocolitica, Shigella and Escherichia coli enteroinvasive.
    Giannini MJ; de Medeiros BM; Bauab TM; Carlos IZ; de Toledo MR; Trabulsi LR; Falcão DP
    Contrib Microbiol Immunol; 1991; 12():164-70. PubMed ID: 1935085
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of a polyvalent protein-polysaccharide dysentery oral vaccine.
    Zhang HM; Li YP; Song LH; Yu XL; Liu NH; Kong XE; Li L; Zhai YL
    Chin Med J (Engl); 1987 May; 100(5):425-8. PubMed ID: 3115716
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral immunization against dysentery.
    Kétyi I; Rauss K; Vertényi A
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):81-5. PubMed ID: 4613142
    [No Abstract]   [Full Text] [Related]  

  • 11. The cellular and humoral immune response after administration to the guinea pig of Shigella flexneri 2a T32--Istrati vaccinal strain by different routes.
    Meitert T; Radu I; Ciudin L; Pencu E; Tonciu M
    Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):267-76. PubMed ID: 395927
    [No Abstract]   [Full Text] [Related]  

  • 12. An outbreak of Sonne shigellosis in a population receiving oral attenuated shigella vaccines.
    Levine MM; Rice PA; Gangarosa EJ; Morris GK; Snyder MJ; Formal SB; Wells JG; Gemski P; Hammond J
    Am J Epidemiol; 1974 Jan; 99(1):30-6. PubMed ID: 4590191
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oral vaccines for preventing intestinal infections (literature review)].
    Kheĭfets LB
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Mar; 51(3):21-8. PubMed ID: 4208437
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral shigella vaccines.
    Hale TL; Formal SB
    Curr Top Microbiol Immunol; 1989; 146():205-11. PubMed ID: 2659269
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful field trials with oral killed Shigella sonnei vaccine.
    Grahneis H
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):75-80. PubMed ID: 4613141
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains.
    Mel D; Gangarosa EJ; Radovanovic ML; Arsic BL; Litvinjenko S
    Bull World Health Organ; 1971; 45(4):457-64. PubMed ID: 4948417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli.
    Noriega FR; Losonsky G; Wang JY; Formal SB; Levine MM
    Infect Immun; 1996 Jan; 64(1):23-7. PubMed ID: 8557344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Live vaccines for the prevention of intestinal infections].
    Sergeev VV; Kreynin LS; Lichoded VG; Elkina CU; Zukova LF; Kaverina KG
    Arch Exp Veterinarmed; 1980; 34(1):87-9. PubMed ID: 6998403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination against the enterobacteria responsible for enteric infections].
    Sansonetti PJ
    Ann Gastroenterol Hepatol (Paris); 1994; 30(2):60-3. PubMed ID: 8210205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity of the guinea pig's eye after vaccination with Shigella sonnei phase I antigen.
    Kerekes L
    Acta Microbiol Acad Sci Hung; 1976; 23(4):353-8. PubMed ID: 799899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.